Mesoblast (MESO) Change in Cash (2016 - 2021)
Mesoblast's (MESO) quarterly Change in Cash came in at -$21.2 million in Q4 2021, up 33.25% year-on-year from -$15.9 million in Q4 2020, and down 3.59% quarter-over-quarter from -$20.4 million in Q3 2021.
Mesoblast (MESO) Change in Cash (2016 - 2021) Analysis & Trends
Mesoblast has disclosed Change in Cash across 5 years of filings, most recently posting -$21.2 million for Q4 2021.
- Change in Cash for Q4 2021 came in at -$21.2 million, up 33.25% year-over-year; the trailing twelve-month figure through Dec 2021 was -$95.1 million (down 65.19% YoY), and the FY2025 annual result was $97.5 million, up 1274.3% from the prior year.
- Change in Cash came in at -$21.2 million for Q4 2021 at Mesoblast, down from -$20.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $34.7 million in Q1 2017 to a low of -$31.7 million in Q4 2020.
- The 4-year median for Change in Cash is -$20.4 million (2021), against an average of -$6.7 million.
- Across the five-year window, Change in Cash surged 182.5% in 2017 and sank 65.27% in 2018, its largest moves.
- Mesoblast's Change in Cash stood at -$15.4 million in 2017, then jumped by 213.51% to $17.5 million in 2018, then plunged by 281.08% to -$31.7 million in 2020, then surged by 33.25% to -$21.2 million in 2021.
- The last three Change in Cash figures came in at -$21.2 million (Q4 2021), -$20.4 million (Q3 2021), and -$31.7 million (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -21.18 Mn |
| Sep 30, 2021 | -20.45 Mn |
| Dec 31, 2020 | -31.73 Mn |
| Sep 30, 2020 | -21.71 Mn |
| Sep 30, 2018 | 17.52 Mn |
| Jun 30, 2018 | -21.64 Mn |
| Mar 31, 2018 | 12.06 Mn |
| Dec 31, 2017 | -15.44 Mn |
| Sep 30, 2017 | 17.47 Mn |
| Jun 30, 2017 | -23.33 Mn |
| Mar 31, 2017 | 34.72 Mn |
| Dec 31, 2016 | -25.54 Mn |
| Sep 30, 2016 | -21.17 Mn |
| Jun 30, 2016 | -18.11 Mn |